- $2.65bn
- $3.04bn
- $605.49m
Transmedics Group Inc expected to post a loss of 16 cents a share - Earnings Preview
Transmedics Group Inc reports results for the quarter ended in June - Earnings Summary
Brief: Transmedics Group Q2 EPS USD -0.03
Brief: Bridge To Life Divests Certain Assets To Transmedics
Brief: Transmedics Acquires Warm Perfusion Evoss And Cold Perfusion Lifecradle Technologies
Transmedics Group Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Transmedics Signs Definitive Agreement To Buy Summit Aviation
U.S. RESEARCH ROUNDUP- Diamondback Energy, Penumbra, Procore Technologies
TransMedics rallies after upsized convertible debt deal
Brief: Transmedics Group, Inc. Prices $400 Million Of Convertible Senior Notes Due 2028
Transmedics Group Inc reports results for the quarter ended in March - Earnings Summary
Brief: TransMedics Reports First Quarter 2023 Financial Results
Brief: Transmedics Group Expects FY revenue USD 160-170 million
Transmedics Group Inc expected to post a loss of 25 cents a share - Earnings Preview
Transmedics Group Inc reports results for the quarter ended in December - Earnings Summary
Transmedics Group Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Silver miners, Luxury brands, TransMedics Group
TransMedics Group hits record high on sales forecast raise
Transmedics Group Inc reports results for the quarter ended in September - Earnings Summary